(S, R, S) -AHPC-Me
(S, R, S) -AHPC-Me is a potent VHL ligand derived from (S, R, S) -AHPC, designed for targeted protein degradation. It effectively degrades BET proteins with a DC50 below 1 nM in resistant prostate cancer cell models and serves as a key component in the synthesis of the PROTAC degrader ARV-771 for cancer research.
Product Specifications
CAS Number
1948273-02-6
Product Name Alternative
(S, R, S) AHPCMe, (S, R, S) AHPC Me, AHPC-Me, E3 ligase Ligand 1A, Ligands for E3 Ligase, Ligand for E3 Ligase, LigandforE3Ligase, inhibit, E3 ligase-recruiting Moiety, Inhibitor, VHL ligand 2, VHL ligand2, VHL ligand-2, VHL
Field of Research
Pharmacology & Drug Discovery
Purity
99.86% (May vary between batches)
Smiles
C ([C@H] (C (C) (C) C) N) (=O) N1[C@H] (C (N[C@@H] (C) C2=CC=C (C=C2) C3=C (C) N=CS3) =O) C[C@@H] (O) C1
Molecular Formula
C23H32N4O3S
Molecular Weight
444.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
L9375-03E-ML750 100 µL
LYVE-1 (Lymphatic Vessel Endothelial Hyaluronic Acid Receptor, LYVE1, CRSBP1, Extracellular Link Domain Containing 1, Hyaluronic Acid Receptor, HAR, Lymphatic Endothelium Specific Hyaluronan Receptor, Lymphatic Vessel Endothelial Hyaluronan Receptor 1, XLKD1) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
RC208584L3V 200 µL
ZNHIT2 (NM_014205) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 